Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET Â | Source: Intellia Therapeutics, Inc. Deep, stable…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Bybit Lists Syndicate (SYND) as Appchain Revolution Accelerates
DUBAI, UAE, Oct. 27, 2025 /PRNewswire/ --Â Bybit, the world's second-largest cryptocurrency exchange…
Jupiter Endovascular Announces Positive Results From SPIRARE I First-in-human Study Presented at TCT 2025
Vertex Pulmonary Embolectomy System with Transforming Fixation (TFX) Technology Demonstrates Excellent Safety,…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
More than 2,000 Cyclists pedal for Rs. 33.6 Lakhs at the 3rd edition of HCL Cyclothon Chennai
The Cycling Federation of India (CFI) as the technical partner, oversaw event…
Apollomics, Inc. Company Operational Continuity Update
October 13, 2025 21:22 ET Â | Source: Apollomics Inc. FOSTER CITY, Calif.,…
Lamborghini SC63 aims to finish on a positive note in IMSA GTP finale at Petit Le Mans
Daniil Kvyat returns to the wheel of the #63 LMDh alongside Grosjean…
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…